Table of Contents
International Journal of Peptides
Volume 2012, Article ID 256294, 8 pages
http://dx.doi.org/10.1155/2012/256294
Review Article

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

Division of Diabetic Complications, Baker IDI Heart and Diabetes Institute, P.O. Box 6492 Melbourne, VIC 8008, Australia

Received 15 September 2011; Accepted 5 December 2011

Academic Editor: Suhn Hee Kim

Copyright © 2012 Chris Tikellis and M. C. Thomas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Crowley, S. B. Gurley, M. I. Oliverio et al., “Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system,” The Journal of Clinical Investigation, vol. 115, no. 4, pp. 1092–1099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Donoghue, F. Hsieh, E. Baronas et al., “A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9,” Circulation Research, vol. 87, no. 5, pp. E1–E9, 2000. View at Google Scholar · View at Scopus
  3. A. J. Turner and N. M. Hooper, “The angiotensin-converting enzyme gene family: genomics and pharmacology,” Trends in Pharmacological Sciences, vol. 23, no. 4, pp. 177–183, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. G. I. Rice, D. A. Thomas, P. J. Grant, A. J. Turner, and N. M. Hooper, “Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism,” Biochemical Journal, vol. 383, part 1, pp. 45–51, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. C. Thomas, R. J. Pickering, D. Tsorotes et al., “Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse,” Circulation Research, vol. 107, no. 7, pp. 888–897, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. Tikellis, K. Bialkowski, J. Pete et al., “ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes,” Diabetes, vol. 57, no. 4, pp. 1018–1025, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. C. Wei, B. Tian, G. Perry et al., “Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene,” American Journal of Physiology, vol. 282, no. 6, pp. H2254–H2258, 2002. View at Google Scholar · View at Scopus
  8. S. R. Tipnis, N. M. Hooper, R. Hyde, E. Karran, G. Christie, and A. J. Turner, “A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase,” The Journal of Biological Chemistry, vol. 275, no. 43, pp. 33238–33243, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. K. Kuba, L. Zhang, Y. Imai et al., “Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload,” Circulation Research, vol. 101, no. 4, pp. e32–e42, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. Vickers, P. Hales, V. Kaushik et al., “Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase,” The Journal of Biological Chemistry, vol. 277, no. 17, pp. 14838–14843, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. H. Zhang, J. Wada, K. Hida et al., “Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys,” The Journal of Biological Chemistry, vol. 276, no. 20, pp. 17132–17139, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. Kowalczuk, A. Bröer, N. Tietze, J. M. Vanslambrouck, J. E. J. Rasko, and S. Bröer, “A protein complex in the brush-border membrane explains a Hartnup disorder allele,” The FASEB Journal, vol. 22, no. 8, pp. 2880–2887, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. D. W. Lambert, N. E. Clarke, N. M. Hooper, and A. J. Turner, “Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain,” FEBS Letters, vol. 582, no. 2, pp. 385–390, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. C. I. Johnston, “Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling,” Hypertension, vol. 23, no. 2, pp. 258–268, 1994. View at Google Scholar · View at Scopus
  15. Min Ae Lee, M. Bohm, M. Paul, and D. Ganten, “Tissue renin-angiotensin systems: their role in cardiovascular disease,” Circulation, vol. 87, no. 5, pp. IV7–IV13, 1993. View at Google Scholar · View at Scopus
  16. D. S. Jacoby and D. J. Rader, “Renin-angiotensin system and atherothrombotic disease: from genes to treatment,” Archives of Internal Medicine, vol. 163, no. 10, pp. 1155–1164, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. R. Candido, K. A. Jandeleit-Dahm, Z. Cao et al., “Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice,” Circulation, vol. 106, no. 2, pp. 246–253, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Candido, T. J. Allen, M. Lassila et al., “Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis,” Circulation, vol. 109, no. 12, pp. 1536–1542, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. L. A. Cassis, M. Gupte, S. Thayer et al., “ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice,” American Journal of Physiology, vol. 296, no. 5, pp. H1660–H1665, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. X. L. Chen, P. E. Tummala, M. T. Olbrych, R. W. Alexander, and R. M. Medford, “Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells,” Circulation Research, vol. 83, no. 9, pp. 952–959, 1998. View at Google Scholar · View at Scopus
  21. A. E. Loot, J. G. Schreiber, B. Fisslthaler, and I. Fleming, “Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase,” Journal of Experimental Medicine, vol. 206, no. 13, pp. 2889–2896, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. J. A. P. Daemen, D. M. Lombardi, F. T. Bosman, and S. M. Schwartz, “Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall,” Circulation Research, vol. 68, no. 2, pp. 450–456, 1991. View at Google Scholar · View at Scopus
  23. J. L. Probstfield and K. D. O'Brien, “Progression of cardiovascular damage: the role of renin-angiotensin system blockade,” American Journal of Cardiology, vol. 105, no. 1, supplement, pp. 10A–20A, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. C. M. Ferrario, A. J. Trask, and J. A. Jessup, “Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function,” American Journal of Physiology, vol. 289, no. 6, pp. H2281–H2290, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. Tesanovic, A. Vinh, T. A. Gaspari, D. Casley, and R. E. Widdop, “Vasoprotective and atheroprotective effects of angiotensin (1–7) in apolipoprotein E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1606–1613, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. J. C. Sluimer, J. M. Gasc, I. Hamming et al., “Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions,” The Journal of Pathology, vol. 215, no. 3, pp. 273–279, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. C. Tikellis, C. I. Johnston, J. M. Forbes et al., “Characterization of renal angiotensin—converting enzyme 2 in diabetic nephropathy,” Hypertension, vol. 41, no. 3, pp. 392–397, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. L. Stanziola, L. J. Greene, and R. A. S. Santos, “Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats,” American Journal of Hypertension, vol. 12, no. 10, part 1, pp. 1021–1029, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. I. F. Benter, M. H. M. Yousif, F. M. Al-Saleh, R. Raghupathy, M. C. Chappell, and D. I. Diz, “Angiotensin-(1–7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-l-arginine methyl ester,” Journal of Cardiovascular Pharmacology, vol. 57, no. 5, pp. 559–567, 2011. View at Publisher · View at Google Scholar · View at PubMed
  30. S. B. Gurley, A. Allred, T. H. Le et al., “Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice,” The Journal of Clinical Investigation, vol. 116, no. 8, pp. 2218–2225, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. B. Gurley and T. M. Coffman, “Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages,” Experimental Physiology, vol. 93, no. 5, pp. 538–542, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. G. Y. Oudit, Z. Kassiri, M. P. Patel et al., “Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice,” Cardiovascular Research, vol. 75, no. 1, pp. 29–39, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. A. Crackower, R. Sarao, G. Y. Oudit et al., “Angiotensin-converting enzyme 2 is an essential regulator of heart function,” Nature, vol. 417, no. 6891, pp. 822–828, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. Yamazato, Y. Yamazato, C. Sun, C. Diez-Freire, and M. K. Raizada, “Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats,” Hypertension, vol. 49, no. 4, pp. 926–931, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. Y. Feng, H. Xia, Y. Cai et al., “Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension,” Circulation Research, vol. 106, no. 2, pp. 373–382, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. Y. Feng, X. Yue, H. Xia et al., “Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation,” Circulation Research, vol. 102, no. 6, pp. 729–736, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. D. I. Diz, M. A. Garcia-Espinosa, S. Gegick et al., “Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats,” Experimental Physiology, vol. 93, no. 5, pp. 694–700, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. F. Pieruzzi, Z. A. Abassi, and H. R. Keiser, “Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure,” Circulation, vol. 92, no. 10, pp. 3105–3112, 1995. View at Google Scholar · View at Scopus
  39. M. Ruzicka, F. W. Keeley, and F. H. H. Leenen, “The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin,” Circulation, vol. 90, no. 4, pp. 1989–1996, 1994. View at Google Scholar · View at Scopus
  40. A. T. Hirsch, C. E. Talsness, H. Schunkert, M. Paul, and V. J. Dzau, “Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure,” Circulation Research, vol. 69, no. 2, pp. 475–482, 1991. View at Google Scholar · View at Scopus
  41. S. Hokimoto, H. Yasue, K. Fujimoto et al., “Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction,” Circulation, vol. 94, no. 7, pp. 1513–1518, 1996. View at Google Scholar · View at Scopus
  42. J. I. Sadoshima, Y. Xu, H. S. Slayter, and S. Izumo, “Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro,” Cell, vol. 75, no. 5, pp. 977–984, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Kakishita, K. Nakamura, M. Asanuma et al., “Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor,” Journal of Cardiovascular Pharmacology, vol. 42, supplement 1, pp. S67–S70, 2003. View at Google Scholar
  44. K. T. Weber, Y. Sun, and E. Guarda, “Structural remodeling in hypertensive heart disease and the role of hormones,” Hypertension, vol. 23, no. 6, pp. 869–877, 1994. View at Google Scholar · View at Scopus
  45. M. A. Pfeffer, E. Braunwald, L. A. Moye et al., “Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction—results of the survival and ventricular enlargement trial,” The New England Journal of Medicine, vol. 327, no. 10, pp. 669–677, 1992. View at Google Scholar · View at Scopus
  46. P. J. Garabelli, J. G. Modrall, J. M. Penninger, C. M. Ferrario, and M. C. Chappell, “Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart,” Experimental Physiology, vol. 93, no. 5, pp. 613–621, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. J. A. Stewart Jr., E. Lazartigues, and P. A. Lucchesi, “The angiotensin converting enzyme 2/Ang-(1–7) axis in the heart: a role for mas communication?” Circulation Research, vol. 103, no. 11, pp. 1197–1199, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. Z. Kassiri, J. Zhong, D. Guo et al., “Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction,” Circulation, vol. 2, no. 5, pp. 446–455, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. S. Bodiga, J. C. Zhong, W. Wang et al., “Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit,” Cardiovascular Research, vol. 91, no. 1, pp. 151–161, 2011. View at Publisher · View at Google Scholar · View at PubMed
  50. K. Yamamoto, M. Ohishi, T. Katsuya et al., “Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II,” Hypertension, vol. 47, no. 4, pp. 718–726, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. K. Nakamura, N. Koibuchi, H. Nishimatsu et al., “Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice,” Hypertension Research, vol. 31, no. 10, pp. 1953–1961, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. T. N. Doan, N. Gletsu, J. Cole, and K. E. Bernstein, “Genetic manipulation of the renin-angiotensin system,” Current Opinion in Nephrology and Hypertension, vol. 10, no. 4, pp. 483–491, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Li, J. Zimpelmann, K. Cheng, J. A. Wilkins, and K. D. Burns, “The role of angiotensin converting enzyme 2 in the generation of angiotensin 1–7 by rat proximal tubules,” American Journal of Physiology, vol. 288, no. 2, pp. F353–F362, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. G. Y. Oudit, A. M. Herzenberg, Z. Kassiri et al., “Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis,” American Journal of Pathology, vol. 168, no. 6, pp. 1808–1820, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. J. Zhong, D. Guo, C. B. Chen et al., “Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2,” Hypertension, vol. 57, no. 2, pp. 314–322, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. M. J. Soler, J. Wysocki, M. Ye, J. Lloveras, Y. Kanwar, and D. Batlle, “ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice,” Kidney International, vol. 72, no. 5, pp. 614–623, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. D. W. Wong, G. Y. Oudit, H. Reich et al., “Loss of Angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury,” American Journal of Pathology, vol. 171, no. 2, pp. 438–451, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. A. T. Lely, I. Hamming, H. van Goor, and G. J. Navis, “Renal ACE2 expression in human kidney disease,” The Journal of Pathology, vol. 204, no. 5, pp. 587–593, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. D. G. Kiely, R. I. Cargill, N. M. Wheeldon, W. J. Coutie, and B. J. Lipworth, “Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale,” Cardiovascular Research, vol. 33, no. 1, pp. 201–208, 1997. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Imai, K. Kuba, S. Rao et al., “Angiotensin-converting enzyme 2 protects from severe acute lung failure,” Nature, vol. 436, no. 7047, pp. 112–116, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. W. Li, M. J. Moore, N. Vasllieva et al., “Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus,” Nature, vol. 426, no. 6965, pp. 450–454, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. K. Kuba, Y. Imai, S. Rao et al., “A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury,” Nature Medicine, vol. 11, no. 8, pp. 875–879, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. F. Lovren, Y. Pan, A. Quan et al., “Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis,” American Journal of Physiology, vol. 295, no. 4, pp. H1377–H1384, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. B. Dong, C. Zhang, J. B. Feng et al., “Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1270–1276, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. C. Díez-Freire, J. Vázquez, M. F. Correa De Adjounian et al., “ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR,” Physiological Genomics, vol. 27, no. 1, pp. 12–19, 2006. View at Publisher · View at Google Scholar · View at PubMed
  66. B. Rentzsch, M. Todiras, R. Iliescu et al., “Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function,” Hypertension, vol. 52, no. 5, pp. 967–973, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. J. Wysocki, M. Ye, E. Rodriguez et al., “Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension,” Hypertension, vol. 55, no. 1, pp. 90–98, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. G. Y. Oudit, G. C. Liu, J. Zhong et al., “Human recombinant ACE2 reduces the progression of diabetic nephropathy,” Diabetes, vol. 59, no. 2, pp. 529–538, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. C. X. Liu, Q. Hu, Y. Wang et al., “Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition,” Molecular Medicine, vol. 17, no. 1-2, pp. 59–69, 2011. View at Publisher · View at Google Scholar · View at PubMed
  70. A. B. Goulter, M. Avella, K. M. Botham, and J. Elliott, “Chylomicron-remnant-like particles inhibit the basal nitric oxide pathway in porcine coronary artery and aortic endothelial cells,” Clinical Science, vol. 105, no. 3, pp. 363–371, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. R. Studer, H. Reinecke, B. Muller, J. Holtz, H. Just, and H. Drexler, “Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction,” The Journal of Clinical Investigation, vol. 94, no. 1, pp. 301–310, 1994. View at Google Scholar · View at Scopus
  72. L. S. Zisman, R. S. Keller, B. Weaver et al., “Increased angiotensin-(1–7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2,” Circulation, vol. 108, no. 14, pp. 1707–1712, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. C. Communal, M. Singh, B. Menon, Z. Xie, W. S. Colucci, and K. Singh, “β1 integrins expression in adult rat ventricular myocytes and its role in the regulation of β-adrenergic receptor-stimulated apoptosis,” Journal of Cellular Biochemistry, vol. 89, no. 2, pp. 381–388, 2003. View at Publisher · View at Google Scholar · View at PubMed
  74. M. Donoghue, H. Wakimoto, C. T. Maguire et al., “Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 9, pp. 1043–1053, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Masson, S. A. Nicklin, M. A. Craig et al., “Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2,” Hypertension, vol. 53, no. 4, pp. 694–700, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. S. Der Sarkissian, J. L. Grobe, L. Yuan et al., “Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology,” Hypertension, vol. 51, no. 3, pp. 712–718, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. J. Zhong, R. Basu, D. Guo et al., “Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction,” Circulation, vol. 122, no. 7, pp. 717–728, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. N. Hayashi, K. Yamamoto, M. Ohishi et al., “The counterregulating role of ACE2 and ACE2-mediated angiotensin 1–7 signaling against angiotensin II stimulation in vascular cells,” Hypertension Research, vol. 33, no. 11, pp. 1182–1185, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. G. Raffai, M. J. Durand, and J. H. Lombard, “Acute and chronic angiotensin-(1–7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats,” American Journal of Physiology, vol. 301, no. 4, pp. H1341–H1352, 2011. View at Publisher · View at Google Scholar · View at PubMed
  80. J. C. Zhong, D. Y. Huang, Y. M. Yang et al., “Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats,” Hypertension, vol. 44, no. 6, pp. 907–912, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. J. A. Hernández Prada, A. J. Ferreira, M. J. Katovich et al., “Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents,” Hypertension, vol. 51, no. 5, pp. 1312–1317, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. A. J. Ferreira, V. Shenoy, Y. Qi et al., “Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases,” Experimental Physiology, vol. 96, no. 3, pp. 287–294, 2011. View at Publisher · View at Google Scholar · View at PubMed
  83. A. J. Ferreira, V. Shenoy, Y. Yamazato et al., “Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 11, pp. 1048–1054, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. R. A. Fraga-Silva, B. S. Sorg, M. Wankhede et al., “ACE2 activation promotes antithrombotic activity,” Molecular Medicine, vol. 16, no. 5-6, pp. 210–215, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus